Pluri Inc. Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Pluri Inc. (PLUR) reported Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $361.00 thousand for the 6-month period ending 2022-12-31, per its 10-Q filed 2023-02-13.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2023-02-13
- Pluri Inc. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2018-09-30 was $27.00K, a 66.25% decline year-over-year.
- Pluri Inc. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2018-06-30 was $0.00.
- Pluri Inc. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2018-03-31 was $0.00.
- Pluri Inc. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2017-12-31 was $1.32M.
- Pluri Inc. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2021 was $1.92M, a 1842.42% increase from fiscal 2020.
- Pluri Inc. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2020 was $99.00K, a 93.55% decline from fiscal 2019.
- Pluri Inc. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2019 was $1.54M, a 9.32% increase from fiscal 2018.
- Pluri Inc. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2018 was $1.41M, a 8.29% decline from fiscal 2017.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 0 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 1 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 3 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 6 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 6 month as first filed | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 9 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $361.00K 10-Q · filed 2023-02-13 | ||||||
| 2021-06-30 | $1.92M 10-K · filed 2021-09-13 | ||||||
| 2020-06-30 | $99.00K 10-K · filed 2021-09-13 | ||||||
| 2019-06-30 | $1.54M 10-K · filed 2020-09-10 | ||||||
| 2018-09-30 | $27.00K 10-Q · filed 2018-11-07 | $27.00K derived: sum of 2 quarters · filed 2020-09-10 | $27.00K derived: sum of 3 quarters · filed 2020-09-10 | $1.35M derived: sum of 4 quarters · filed 2020-09-10 | |||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $0.00 derived: sum of 2 quarters · filed 2020-09-10 | $1.32M derived: sum of 3 quarters · filed 2020-09-10 | $1.41M 10-K · filed 2020-09-10 | |||
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-06 | $1.32M derived: sum of 2 quarters · filed 2019-05-06 | $1.41M 10-Q · filed 2019-05-06 | $1.41M derived: sum of 4 quarters · filed 2019-09-12 | |||
| 2017-12-31 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | $1.41M 10-Q · filed 2019-02-06 | $80.00K 10-Q · filed 2018-02-06 | $1.41M derived: sum of 3 quarters · filed 2019-09-12 | |||
| 2017-10-31 | $1.41M 10-Q · filed 2018-02-06 | ||||||
| 2017-09-30 | $80.00K 10-Q · filed 2018-11-07 | $80.00K derived: sum of 2 quarters · filed 2019-09-12 | |||||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $1.53M 10-K · filed 2019-09-12 | |||||
| 2017-03-31 | $1.53M 10-Q · filed 2018-05-09 | ||||||
| 2015-06-30 | $1.20M 10-K · filed 2015-09-09 | $1.20M 10-K · filed 2017-09-07 | |||||
| 2014-06-30 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $195.00K 10-K · filed 2016-09-07 | |||||
| 2014-03-31 | $184.00K 10-Q · filed 2015-05-06 | ||||||
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $2.69M 10-K · filed 2015-09-09 | |||||
| 2013-03-31 | $2.69M 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |